Alexithymia impact on type 1 and type 2 diabetes: a case-control study
Leila Mnif1, Rahma Damak1, Fatma Mnif2
1Department of Psychiatry A, University Medical Center Hédi Chaker, 3029 Sfax, Tunisia.
Annales D'Endocrinologie
|August 24, 2014
Summary
Alexithymia is more prevalent in type 1 diabetes and linked to higher blood sugar. Early detection and treatment of alexithymia in diabetes patients are crucial for better health outcomes.
Area of Science:
- Endocrinology and Diabetes Research
- Psychosomatic Medicine
- Clinical Psychology
Background:
- Alexithymia, characterized by difficulties in identifying and describing emotions, is increasingly recognized as a factor influencing chronic disease management.
- Understanding the prevalence and impact of alexithymia in diabetes mellitus is essential for optimizing patient care.
Purpose of the Study:
- To investigate the prevalence of alexithymia in patients with type 1 and type 2 diabetes.
- To examine the association between alexithymia and clinical/therapeutic characteristics of diabetes.
- To explore the relationship between alexithymia and emotional disorders in diabetic populations.
Main Methods:
- A cohort of 125 diabetic patients (50 type 1, 75 type 2) and matched control groups were assessed.
- The Toronto Alexithymia Scale (TAS) was used to measure alexithymia.
- The Hospital Anxiety and Depression Scale (HADS) was employed to evaluate emotional disorders.
Main Results:
- Type 1 diabetics exhibited higher alexithymia rates than controls; type 2 diabetics showed elevated cognitive alexithymia scores.
- Alexithymic type 1 diabetics had higher fasting blood glucose levels (P=0.021) and a correlation between erectile dysfunction and difficulty identifying feelings (P=0.012).
- Depression predicted alexithymia in type 1 diabetes (P=0.04), while psychiatric history indicated alexithymia in type 2 diabetes (P=0.042).
Conclusions:
- Alexithymia significantly impacts both type 1 and type 2 diabetes.
- Identifying and managing alexithymia is vital for improving the prognosis of diabetes.
- Integrating psychological assessments, including alexithymia screening, can enhance diabetes care strategies.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
54
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
54
01:26Type II Diabetes I: Introduction
8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
01:24Type II Diabetes II: Pathophysiology
12
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
12
01:22Diabetes Mellitus: Overview and Type I Subtype
5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
01:22Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
01:12Type I Diabetes I: Introduction
39
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
39